Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.
Open Access
- 1 October 1987
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 80 (4), 1114-1124
- https://doi.org/10.1172/jci113168
Abstract
Human alveolar macrophages release chemotactic activity for neutrophils, providing a role for alveolar macrophages in regulating inflammation in the lung. As alveolar macrophages produce large amounts of leukotriene B4 (LTB4), a chemotactically active lipoxygenase product of arachidonic acid, we investigated the contribution of LTB4 to the total neutrophil chemotactic activity produced by these cells. Normal human alveolar macrophages were recovered by bronchoalveolar lavage from healthy volunteers and incubated either with the calcium ionophore A23187 for 1 h, or with opsonized zymosan particles or latex beads for 3 h. Nordihydroguaretic acid (NDGA), a relatively specific lipoxygenase inhibitor, blocked the release of neutrophil chemotactic activity after all three stimuli in a dose-dependent manner. This correlated with blockade of LTB4 production as measured by high performance liquid chromatography using freshly isolated alveolar macrophages, as well as blockade of [3H]LTB4 production by macrophages prelabeled with [3H]arachidonate. Molecular sieve chromatography using Sephadex G-50 confirmed that essentially all of the chemotactic activity in the stimulated macrophage supernatants co-eluted with authentic [3H]LTB4, and that NDGA completely blocked the chemotactic activity in the eluting fractions. Readdition of authentic LTB4 (1 X 10(-7) M) to the NDGA-blocked macrophage supernatants restored the chemotactic activity in the supernatants. The macrophage supernatants did not contain platelet-activating factor-like activity, as measured by the stimulation of [3H]serotonin release from rabbit platelets, and by high performance liquid chromatography. NDGA did not change the protein-secretion profiles of fresh alveolar macrophages, or of macrophages prelabeled with [35S]methionine. The complement (C) components C5adesarg were not detected in any of the supernatants by radioimmunoassay. Concentration of the supernatants by positive pressure filtration (5,000-D membrane) did not augment chemotactic activity in the stimulated supernatants or uncover chemotactic activity in the NDGA-blocked supernatants. As with the 3-h studies, when alveolar macrophages were incubated overnight with opsonized zymosan, all of the increase in chemotactic activity could also be blocked by NDGA. These data indicate that LTB4 is the predominant neutrophil chemotactic factor secreted by the normal resident human alveolar macrophage in response to two major types of stimuli, calcium fluxes across the cell membrane and the phagocytosis of opsonized particulates.This publication has 43 references indexed in Scilit:
- Release of platelet‐activating factor (PAF‐acether) from alveolar macrophages by the calcium ionophore A 23187 and phagocytosisEuropean Journal of Clinical Investigation, 1980
- The Macrophage as an Effector CellNew England Journal of Medicine, 1980
- Human Alveolar Macrophage-derived Chemotactic Factor for NeutrophilsJournal of Clinical Investigation, 1980
- Alveolar macrophage lipoxygenase products of arachidonic acid: Isolation and recognition as the predominant constituents of the neutrophil chemotactic activity elaborated by alveolar macrophagesCellular Immunology, 1980
- Novel effects of 1-0-hexadecyl-2-acyl-sn-glycero-3-phosphorylcholine mediators on human leukocyte function: Delineation of the specific roles of the acyl substituentsBiochemical and Biophysical Research Communications, 1980
- Monohydroxyeicosatetraenoic acids (HETEs) induce degranulation of human neutrophils.The Journal of Immunology, 1980
- A macrophage receptor for (mannose/glucosamine)-glycoproteins of potential importance in phagocytic activityBiochemical and Biophysical Research Communications, 1980
- Alveolar macrophage-derived chemotactic factor: kinetics of in vitro production and partial characterization.Journal of Clinical Investigation, 1980
- Human neutrophil-derived platelet activating factor.The Journal of Immunology, 1980
- REGULATION OF THE RELEASE OF ALVEOLAR MACROPHAGE-DERIVED NEUTROPHIL CHEMOTACTIC FACTORPublished by Elsevier ,1980